This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pitot, H. C. Articles by Poland, A. Search for Related Content PubMed PubMed Citation Articles by Pitot, H. C. Articles by Poland, A.

Quantitative Evaluation of the Promotion by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of Hepatocarcinogenesis from Diethylnitrosamine¹

McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706

In order to test the potential of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) as a promoter of hepatocarcinogenesis, rats which had received a single 10-mg/kg dose of diethylnitrosamine (DEN) following partial hepatectomy were given TCDD (0.14 and 1.4 µg/kg s.c. once every 2 weeks) for 7 months. Animals which received (a) only a single initiating dose of DEN after partial hepatectomy and no further treatment of (b) TCDD alone with no initiating dose of DEN exhibited relatively few enzyme-altered foci and no hepatocellular carcinomas. However, animals initiated with DEN and then given TCDD had a marked increase in enzyme-altered foci. At the higher dose of TCDD, hepatocellular carcinomas were present in five of seven rats. By means of three different enzyme markers used to evaluate the phenotypes of the enzyme-altered foci, a distinct phenotype heterogeneity of the foci was noted with a shift towards phenotypes exhibiting a greater deviation from normal liver when TCDD was given following DEN-partial hepatectomy. Quantitation of the numbers of enzyme-altered foci was performed by relating measurements made from two-dimensional tissue sections to the numbers of foci per unit volume of liver using relationships established in the field of stereology. The total volume of the liver occupied by the enzyme-altered foci, but not their number, increased with the dose of TCDD administered following DEN-partial hepatectomy. These studies demonstrate that TCDD is a potent promoting agent for hepatocarcinogenesis.

¹ This study was supported in part by Grants CA-07175 and CA-22484 from the National Cancer Institute and Grant ES-00965 from the National Institute of Environmental Health Sciences.

² To whom requests for reprints should be addressed.

³ Recipient of Research Career Development Award K-04ES-0017.

Received 2/22/80. Accepted 6/19/80.

This article has been cited by other articles:

				K. A. Mitchell, C. A. Lockhart, G. Huang, and C. J. Elferink Sustained Aryl Hydrocarbon Receptor Activity Attenuates Liver Regeneration Mol. Pharmacol., July 1, 2006; 70(1): 163 - 170. [Abstract] [Full Text] [PDF]

				T. L. Thomae, E. A. Stevens, A. L. Liss, N. R. Drinkwater, and C. A. Bradfield The Teratogenic Sensitivity to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Modified by a Locus on Mouse Chromosome 3 Mol. Pharmacol., March 1, 2006; 69(3): 770 - 775. [Abstract] [Full Text] [PDF]

				J. A. Popp, E. Crouch, and E. E. McConnell A Weight-of-Evidence Analysis of the Cancer Dose-Response Characteristics of 2,3,7,8-Tetrachlorodibenzodioxin (TCDD) Toxicol. Sci., February 1, 2006; 89(2): 361 - 369. [Abstract] [Full Text] [PDF]

				J. R. Hailey, N. J. Walker, D. M. Sells, A. E. Brix, M. P. Jokinen, and A. Nyska Classification of Proliferative Hepatocellular Lesions in Harlan Sprague-Dawley Rats Chronically Exposed to Dioxin-Like Compounds Toxicol Pathol, January 1, 2005; 33(1): 165 - 174. [Abstract] [Full Text] [PDF]

				M. E. Wyde, A. P. J. M. Braen, M. Hejtmancik, J. D. Johnson, J. D. Toft, J. C. Blake, S. D. Cooper, J. Mahler, M. Vallant, J. R. Bucher, et al. Oral and Dermal Exposure to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) Induces Cutaneous Papillomas and Squamous Cell Carcinomas in Female Hemizygous Tg.AC Transgenic Mice Toxicol. Sci., November 1, 2004; 82(1): 34 - 45. [Abstract] [Full Text] [PDF]

				S. Tomita, H.-B. Jiang, T. Ueno, S. Takagi, K. Tohi, S.-i. Maekawa, A. Miyatake, A. Furukawa, F. J. Gonzalez, J. Takeda, et al. T Cell-Specific Disruption of Arylhydrocarbon Receptor Nuclear Translocator (Arnt) Gene Causes Resistance to 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Induced Thymic Involution J. Immunol., October 15, 2003; 171(8): 4113 - 4120. [Abstract] [Full Text] [PDF]

				M. E. Wyde, T. Cambre, M. Lebetkin, S. R. Eldridge, and N. J. Walker Promotion of Altered Hepatic Foci by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and 17{beta}-estradiol in Male Sprague-Dawley Rats Toxicol. Sci., August 1, 2002; 68(2): 295 - 303. [Abstract] [Full Text] [PDF]

				S. Bohnenberger, B. Wagner, H.-J. Schmitz, and D. Schrenk Inhibition of apoptosis in rat hepatocytes treated with `non-dioxin-like' polychlorinated biphenyls Carcinogenesis, October 1, 2001; 22(10): 1601 - 1605. [Abstract] [Full Text] [PDF]

				M. Viluksela, Y. Bager, J. T. Tuomisto, G. Scheu, M. Unkila, R. Pohjanvirta, S. Flodström, V.-M. Kosma, J. Mäki-Paakkanen, T. Vartiainen, et al. Liver Tumor-promoting Activity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant Rat Strains Cancer Res., December 1, 2000; 60(24): 6911 - 6920. [Abstract] [Full Text]

				N. J. Walker, A. M. Tritscher, R. C. Sills, G. W. Lucier, and C. J. Portier Hepatocarcinogenesis in Female Sprague-Dawley Rats following Discontinuous Treatment with 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicol. Sci., April 1, 2000; 54(2): 330 - 337. [Abstract] [Full Text] [PDF]

				M. E. Wyde, J. Seely, G. W. Lucier, and N. J. Walker Toxicity of Chronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Diethylnitrosamine-Initiated Ovariectomized Rats Implanted with Subcutaneous 17 {beta}-Estradiol Pellets Toxicol. Sci., April 1, 2000; 54(2): 493 - 499. [Abstract] [Full Text] [PDF]

				Regulations and Advisories Toxicology and Industrial Health, April 1, 2000; 16(3-5): 173 - 201. [PDF]

				D. Wolfle, S. Marotzki, D. Dartsch, W. Schafer, and H. Marquardt Induction of cyclooxygenase expression and enhancement of malignant cell transformation by 2,3,7,8-tetrachlorodibenzo- p-dioxin Carcinogenesis, January 1, 2000; 21(1): 15 - 21. [Abstract] [Full Text] [PDF]

				S. K. Kolluri, C. Weiss, A. Koff, and M. Göttlicher p27Kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells Genes & Dev., July 1, 1999; 13(13): 1742 - 1753. [Abstract] [Full Text]

				R. Tennant, B. Margolin, M. Shelby, E Zeiger, J. Haseman, J Spalding, W Caspary, M Resnick, S Stasiewicz, B Anderson, et al. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays Science, May 22, 1987; 236(4804): 933 - 941. [Abstract] [PDF]

				U. G. Ahlborg and K. Victorin Impact On Health of Chlorinated Dioxins and Other Trace Organic Emissions Waste Management Research, January 1, 1987; 5(1): 203 - 224. [Abstract] [PDF]

				D. Mukerjee and D. H. Cleverly Risk From Exposure To Polychlorinated Dibenzo-p-Dioxins and Dibenzofurans Emitted From Municipal Incinerators Waste Management Research, January 1, 1987; 5(1): 269 - 283. [Abstract] [PDF]

				T. Umbreit, E. Hesse, and M. Gallo Bioavailability of dioxin in soil from a 2,4,5-T manufacturing site Science, April 25, 1986; 232(4749): 497 - 499. [Abstract] [PDF]

				P. Cerutti Prooxidant states and tumor promotion Science, January 25, 1985; 227(4685): 375 - 381. [Abstract] [PDF]

				G. P. Lahvis, S. L. Lindell, R. S. Thomas, R. S. McCuskey, C. Murphy, E. Glover, M. Bentz, J. Southard, and C. A. Bradfield Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice PNAS, September 12, 2000; 97(19): 10442 - 10447. [Abstract] [Full Text] [PDF]